Retreatment with initial daily interferon alfa-2b based on body surface area in combination with ribavirin leads to improved viral clearance in virologic nonresponders to standard therapy with interferon and ribavirin

✍ Scribed by Yien Kwo, Paul; Lumeng, Lawrence; Babish, Michael; Behrle, Kevin; Corasanti, James; Hurwich, Daniel; Jones, Bruce; Kim, Lawrence

• Book ID: 124133803
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 190 KB
• Volume: 120
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)81890-2